Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  E-QURE Corp    EQUR

E-QURE CORP (EQUR)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCalendarCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
12/06/2017 12/12/2017 12/13/2017 12/14/2017 12/15/2017 Date
0.061(c) 0.05(c) 0.06(c) 0(c) 0.044(c) Last
22 700 57 500 8 000 12 47 503 Volume
-18.03% +20.00% -100.00% Change
More quotes
Company
E-QURE Corp. engages in the provision of medical devices.Its product includes the Bioelectrical Signal Therapy, which is used to treat chronic wounds which include Diabetic Foot Ulcers, Pressure (Decubitus) Ulcers, and Vascular (Arterial and Venous) Leg Ulcers.The company was founded on August 31,... 
More about the company
Latest news on E-QURE CORP
11/15 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
08/18 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
06/01 E QURE : Was Issued a New Research Report
05/25 E QURE : Electrical Stimulation Therapy and E-Qure - A Potential 20x in 18 Month..
05/15 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
03/31 E QURE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULT..
02/23 E QURE : U.S. FDA Approves Increase in Number of Clinical Sites for E-QURE's Piv..
02/21 E-QURE CORP. (OTCMKTS : EQUR) Files An 8-K Other Events
02/21 E-QURE CORP. : Other Events (form 8-K)
02/15 E-QURE CORP : The Public Health Crisis: Chronic Wounds Cost Lives and $50 Billio..
More news
Sector news : Bio Medical Devices
12/15DJSTOCKS TO WATCH : CSX, Aclaris, Alnylam, Rigel
12/15DJALNYLAM PHARMACEUTICALS : Stock Rises as FDA Lifts Study Hold
12/13 France's Sanofi pins hopes on new drugs after setbacks
12/12 Sanofi investors hungry for drug progress and deal news
12/09 Tax-loss selling to pressure 2017's losers in December
More sector news : Bio Medical Devices
Chart E-QURE CORP
Duration : Period :
E-QURE Corp Technical Analysis Chart | EQUR | US26885P1093 | 4-Traders
Managers
NameTitle
Ohad Goren Chief Executive Officer
Ron Weisburg Chairman
Gal Peleg Chief Financial Officer
Itsik Ben Yesha Chief Technology Officer
Michael Sessler Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
E-QURE CORP-53.85%0
GILEAD SCIENCES6.94%98 689
REGENERON PHARMACEUTICALS5.33%41 789
VERTEX PHARMACEUTICALS96.55%36 888
CELLTRION, INC.--.--%23 756
IQVIA HOLDINGS INC34.41%21 227